Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris

Abstract A β-class carbonic anhydrase (CA, EC 4.2.1.1) was cloned from the genome of the Monogenean platyhelminth Gyrodactylus salaris, a parasite of Atlantic salmon. The new enzyme, GsaCAβ has a significant catalytic activity for the physiological reaction, CO₂ + H₂O ⇋ HCO₃⁻ + H⁺ with a kcat of 1.1...

Full description

Bibliographic Details
Main Authors: Aspatwar, A. (Ashok), Barker, H. (Harlan), Aisala, H. (Heidi), Zueva, K. (Ksenia), Kuuslahti, M. (Marianne), Tolvanen, M. (Martti), Primmer, C. R. (Craig R.), Lumme, J. (Jaakko), Bonardi, A. (Alessandro), Tripathi, A. (Amit), Parkkila, S. (Seppo), Supuran, C. T. (Claudiu T.)
Format: Article in Journal/Newspaper
Language:English
Published: Informa 2022
Subjects:
Online Access:http://urn.fi/urn:nbn:fi-fe2022060242171
Description
Summary:Abstract A β-class carbonic anhydrase (CA, EC 4.2.1.1) was cloned from the genome of the Monogenean platyhelminth Gyrodactylus salaris, a parasite of Atlantic salmon. The new enzyme, GsaCAβ has a significant catalytic activity for the physiological reaction, CO₂ + H₂O ⇋ HCO₃⁻ + H⁺ with a kcat of 1.1 × 10⁵ s⁻¹ and a kcat/Km of 7.58 × 10⁶ M⁻¹ × s⁻¹. This activity was inhibited by acetazolamide (KI of 0.46 µM), a sulphonamide in clinical use, as well as by selected inorganic anions and small molecules. Most tested anions inhibited GsaCAβ at millimolar concentrations, but sulfamide (KI of 81 µM), N,N-diethyldithiocarbamate (KI of 67 µM) and sulphamic acid (KI of 6.2 µM) showed a rather efficient inhibitory action. There are currently very few non-toxic agents effective in combating this parasite. GsaCAβ is subsequently proposed as a new drug target for which effective inhibitors can be designed.